[1]
D. Borowicz, A. . Skrobała, M. Kruszyna-Mochalska, and J. Malicki, “Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer”., Radiol Oncol, vol. 56, no. 2, pp. 259–266, Jul. 2022.